PL BioScience is dedicated to deliver cell culture solutions to support the development and clinical implementation of cellular therapeutics
PL BioScience is a young, ambitious and dynamic life science startup. With its operational start in 2015, PL BioScience offers a portfolio of novel products and innovative technologies for cell expansion in research and clinical applications. The company aims to accelerate the translation of basic research into cell therapy, regenerative medicine and therapeutic products.
- PL BioScience is dedicated to deliver cell culture solutions to support the development and clinical implementation of cellular therapeutics
- PL BioScience is committed to working with its customers to cover their needs from bench to bedside
- Our business development team is dedicated to the support of corporate development by establishing strategic collaborations in R&D and manufacturing
- PL BioScience offers a standardized, qualified and GMP-conform human Platelet Lysate for use for research and cell therapy.
- Cell culture supplement is derived from Platelet Rich Plasma which is subjected to a freeze-thaw process to induce growth factors release.
- Obtained from multiple donors units (>300 units) pooled in large batch sizes to produce a consistent product with minimal lot-to-lot variation.
Each donor unit is tested and approved for human use.
- The consistent supply of donor platelets helps stabilize availability and pricing.
- All products are adequately filtered, tested and certified as mycoplasma-free.